BARBATI, Antonella
 Distribuzione geografica
Continente #
EU - Europa 3.439
NA - Nord America 2.092
AF - Africa 1.142
AS - Asia 403
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 7.095
Nazione #
US - Stati Uniti d'America 2.076
IT - Italia 1.763
MA - Marocco 1.142
UA - Ucraina 510
IE - Irlanda 376
SE - Svezia 261
DE - Germania 133
SG - Singapore 132
FI - Finlandia 121
VN - Vietnam 105
HK - Hong Kong 90
RU - Federazione Russa 81
GB - Regno Unito 54
FR - Francia 45
CN - Cina 43
CH - Svizzera 24
BE - Belgio 16
PE - Perù 12
NL - Olanda 11
TR - Turchia 11
PL - Polonia 10
AT - Austria 8
CA - Canada 8
ES - Italia 8
MX - Messico 7
RO - Romania 7
GR - Grecia 5
LB - Libano 5
UZ - Uzbekistan 5
EU - Europa 3
JP - Giappone 3
KR - Corea 3
CL - Cile 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IN - India 2
BG - Bulgaria 1
IQ - Iraq 1
IR - Iran 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
VE - Venezuela 1
Totale 7.095
Città #
Ouezzane 1.142
Chandler 415
Dublin 375
San Mateo 256
Des Moines 129
Jacksonville 108
Dong Ket 105
Medford 105
Princeton 105
Rome 104
Hong Kong 90
Ann Arbor 87
Milan 81
Wilmington 81
Andover 62
Singapore 60
Bari 34
Catania 32
Perugia 32
Beijing 26
Saint Petersburg 23
Naples 22
Palermo 21
Helsinki 20
Padova 19
Altamura 18
Bologna 18
Boardman 17
Florence 17
New York 17
Redwood City 17
Woodbridge 17
Ashburn 14
Lawrence 14
Norwalk 14
Dearborn 13
Brescia 11
Brussels 11
Falls Church 11
Jesi 11
Napoli 11
Dallas 10
Izmir 10
Lima 9
Shanghai 9
Turin 9
Den Haag 8
Auburn Hills 7
Dalmine 7
Genoa 7
Moscow 7
Pescara 7
Pisa 7
San Diego 7
Trieste 7
Chieti 6
Frankfurt Am Main 6
Lausanne 6
Salerno 6
Venice 6
Verona 6
Bucharest 5
Cagliari 5
Filottrano 5
Foligno 5
Los Angeles 5
Mountain View 5
Santa Marinella 5
Torino 5
Cosenza 4
Genova 4
London 4
Misterbianco 4
Novara 4
Parma 4
Pavia 4
Pesaro 4
Reggio Nell'emilia 4
Rio Saliceto 4
Siracusa 4
Taranto 4
Toronto 4
Vicenza 4
Zevio 4
Agrigento 3
Angri 3
Arequipa 3
Cesano Maderno 3
Corleone 3
Livorno 3
Madrid 3
Modena 3
Noicattaro 3
Redmond 3
San Remo 3
Sciacca 3
Simi Valley 3
Terni 3
Tijuana 3
Vazzola 3
Totale 4.060
Nome #
Fisiopatologia del Cordone Ombelicale. 3.119
Renal Consequences of Gestational Diabetes Mellitus in Term Neonates: A Multidisciplinary Approach to the DOHaD Perspective in the Prevention and Early Recognition of Neonates of GDM Mothers at Risk of Hypertension and Chronic Renal Diseases in Later Life 83
Immunoblotting characterization of CA 125 in biological fluids:difference between pregnancy and cancer CA 125 origin. 78
An immunoistochemical study of c-erbB-2 oncoprotein in breast cancer. 75
Immunochemical and immunohistochemical evaluation of lung permeability in ventilated newborn rabbits 71
Umbilical cord hematoma with altered fetal heart rate. A case report. 69
Effect of aminophylline on lung maturation in preterm rabbit fetuses 68
Markers for breast cancer. 67
CA 125 in pregnancy 67
Antigeni oncofetali in gravidanza. 65
Lung maturation and prematurity 63
Amniotic membrane: separation of amniotic mesoderm from amniotic epithelium and isolation of their respective mesenchymal stromal and epithelial cells. 62
Rare immunological presentation in B-cell chronic lymphocytic leukaemia. 61
Analisi dell'oncogene c-erbB-2 nell'adenocarcinoma gastrico mediante FISH. 61
Cytotoxicity of universal dental adhesive systems: Assessment in vitro assays on human gingival fibroblasts 61
Biophysical and biochemical methods for early detection of breast tumours 60
Placental alkaline phosphatase as a marker for ovarian cancer. 59
Value of c-erbB-2 and p53 oncoprotein co-overexpression in human breast cancer. 57
A common aspect of pregnancy and malignancy: Oncofetal antigens. 55
Elevated peritoneal fluid levels of CA 125 in patients with endometriosis. 54
Indagine sulle morti fetali endouterine: incidenza e cause riscontrate nel periodo 1994-2006 53
Liquido Amniotico: fisiologia e patologia 53
Lysosomal glycohydrolases in patients with gynecological cancer. 52
Fetal lung maturity: Diagnostic methods 50
Tumor-associated trypsin inhibitor (TATI) in patients with ovarian carcinoma: comparison with CA 125. 48
CA 125 and PLAP in maternal blood and amniotic fluid during pregnancy. 48
CA 125 in peritoneal fluid: Reliable values at high dilutions. 47
Serum evaluation of p53 protein in gynecological cancer patients. 46
Incidenti del cordone ombelicale 45
Analisi critica dei metodi per la valutazione della maturità polmonare fetale. 45
Antigeni oncofetali: loro possibili implicazioni in medicina fetale. 45
Biochemical parameters of renal impairment/injury and surrogate markers of nephron number in intrauterine growth-restricted and preterm neonates at 30–40 days of postnatal corrected age 45
Risk of breast cancer 43
CA 125 in human fluids:Facts and artifacts. 43
Evaluation of the second generation CA 125 assays 42
The trophoblast and monoclonal antibodies. 42
The measurement of amniotic fluid phosphatidyl glycerol for the assessment of fetal lung maturity. 42
Oncofetal antigens in pregnancy. 41
Endocrinologia in Gravidanza. A) Modificazioni dell’assetto endocrino materno 41
Intrauterine fetal death incidence in the last ten years. 40
Lung permeability of the immature and nearterm fetal rabbit: Immunochemical and immunohistochemical studies 40
The validation of immunoblot SDS-PAGE as a qualitative and quantitative method for the determination of urinary Cystatin C in neonates 40
Increased urinary Cystatin-C levels correlate with reduced renal volumes in neonates with intrauterine growth restriction 39
Ontogeny of CA 125 antigen in pregnancy: Immunoradiometric determination in amniotic fluid and immunohistochemical localization in fetal membranes. 38
Lo sviluppo morfologico del polmone fetale. 38
Aspetti Immunologici della infertilità. Nota IV: ricerca degli anticorpi antispermatozoo mediante la tecnica dell'immunofluorescenza. 38
VALUATION OF BI OCHEMICAL PARAMETER S OF RENAL IMPAIRMENT/INJURY AND SURROGATE MARKER S OF NEPHRON NUMBER IN IUGR AND PRETERM NEONATES AT 30-40 DAYS OF POSTNATAL CORRECTED AGE 38
Biochemical markers of endometriosis 37
Monoclonal antibodies and the trophoblast. 37
HER-2 Amplification in Gastric Cancer Detected by Fluorescence in situ Hybridization. 37
Assessment of fetal lung maturity and prenatal prevention of respiratory distress syndrome. 37
Serum Evaluation of p53 Protein in Patients with Gnaecological Cancer. 36
Hot-flashes in Breast Cancer Survivors: Effectiveness of Low-dosage Fluoxetine. A Pilot Study 36
Placental alkaline phosphatase in ovarian and other tumours 36
CA 125 and endometriosis 36
Serum quantification of HER-2/neu oncoprotein in gynecological patients. 36
Livelli di CA 125 nel siero e nel liquido peritoneale di pazienti con endometriosi. 36
Sviluppo e profilo biochimico del surfattante polmonare 35
Regulation of CA 125 production by amnion and Wish cell in culture. 35
Hook effect in immunoradiometric assay for CA 125 determination in peritoneal fluid: Evidence of high CA 125 levels by a comparative immunoblotting analysis. 34
Biophysical and Biochemical Methods for early Detection of Breast Tumors. 34
CA125 antigen levels in peritoneal fluid of gynecologic patients. 34
La placenta e il liquido amniotico 33
Glucocorticoids and inositol interactions on fetal rabbit lung maturation. 33
The use of aminophylline for the treatment of preterm labor. 33
Effect of aminophylline on lung maturation in preterm rabbit fetuses. 33
Regulation of CA125 Production by amnion cells in culture. 33
Inositol and glucocorticoid in the development of lung stability in male and female rabbit fetuses 33
Immunohistochemical localization of CA 125 antigen in fetal membranes and placental tissue during gestation. 32
QF-PCR and MLPA: a reliable molecular system to detect chromosomal alterations in miscarriages 32
No evidence of the hook effect in peritoneal fluid CA 125 measurement using immunoenzymatic second generation assays: comparison with immunoradiometric assays. 31
Determination of CA 125 in peritoneal fluid: Reliable values at high dilutions. 31
Evidence of oncogene products in gynecological cancer patients 31
Analisi critica dei markers tumorali nella diagnosi del carcinoma ovarico. 31
Indagine sulla frequenza di infezioni da chlamydia in utenti consultoriali in Umbria. 31
Serum and peritoneal fluid CA-125 levels in patients with endometriosis. 30
Marcatori tumorali umorali 30
Ruolo dei Marcatori Umorali nell'Endometriosi 30
Elevated erbB-2 oncoprotein levels in serum of patients with breast cancer. 30
Bronchial washing as a model of R.D.S. in the adult. 30
Regulation of CA125 production by amnion and Wish cells in culture 30
Monoclonal antibodies and their application in gestational trophoblastic neoplasia 30
Identification of c-erbB-2 oncoprotein in serum: Elevated levels in breast cancer patients. 30
Main clinical analyses on amniotic fluid. 29
Effects of aminophylline on uterine activity 29
REDUCED RENAL VOLUMES AND ELEVATED LEVELS OF CYSTATIN-C IN THE URINE OF NEONATES WITH IUGR 29
Produzione di anticorpi monoclonali verso il sinciziotrofoblasto. 28
p53 and HER-2 protein co-overexpression in human breast cancer 27
Clinical value of serum c-erbB-2 vis-a-vis 3D echography in patients with breast cancer. 27
Screening ultrasonografico per la ricerca delle neoplasie ovariche ed endometriali in pazienti con età>45 anni: risultati preliminari 27
Identificazione del marker tumorale CA 125 nel liquido seminale. 27
Complete responce with paclitaxel (taxol) in metastatic breast cancer during pregnancy. 26
CA125 is released by human amnion cells in culture 26
Studi sull'ontogenesi del marker oncofetale CA 125. 26
Evaluation of IRMA-II and ETI-II assay in serum and peritoneal fluid CA 125 determination 25
PLAP, TATI and CA 125 in ovarian cancer. 24
Fisiologia funzionale feto-placentare. 23
Diagnosi e trattamento dell'immaturità polmonare. 21
Valutazione del TATI come marker tumorale nella patologia oncologica. 21
Fosfatasi alcalina placentare e CA 125 nei tumori ovarici. 21
Totale 7.166
Categoria #
all - tutte 19.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020704 41 39 85 32 58 31 96 38 116 40 63 65
2020/20211.191 49 142 73 142 280 93 68 12 105 39 62 126
2021/2022945 25 154 35 42 31 18 17 292 13 39 90 189
2022/20232.683 144 106 46 107 114 277 1.151 84 539 18 69 28
2023/2024809 57 77 37 56 47 21 101 49 65 67 104 128
2024/202540 40 0 0 0 0 0 0 0 0 0 0 0
Totale 7.261